- Home
- Posts
- 🧪 Lab Sheet: Hepion to Debut on OTCQB Venture Market June 25 as “HEPA”
🧪 Lab Sheet: Hepion to Debut on OTCQB Venture Market June 25 as “HEPA”
iBio (IBIO) reports its engineered amylin-receptor antibody slashed food intake 60% in obese-mouse trials, matching advanced DACRA peptide results.
Jun 26, 2025
Street Sheet Research Members Only
This content is for Street Sheet Research subscribers. Click the button below to join. You'll receive our weekly research report, monthly deep-dives, and instant access to The Street Feed.
JOIN STREET SHEET RESEARCH FOR JUST $99